Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More

Apexbio Technology LLC R-1-3-BUTANEDIOL-200MG
SDP

Catalog No. 5000570090
Encompass_Preferred

(R)-(-)-1 3-Butanediol (CAS No 6290-03-5) is a chiral compound utilized in various biomedical research fields due to its unique stereochemistry and metabolic properties Originating from natural fermentation processes and synthetic methods it acts primarily on metabolic pathways associated with energy production This compound is known for its ability to affect cellular energy balance influencing pathways involved in glycolysis and gluconeogenesis In vitro it displays activity typically in the nanomolar to low micromolar range making it suitable for precise biochemical studies Common applications include its use in cell models to study metabolic disorders in animal studies to evaluate neurological effects and in drug screening as a potential therapeutic agent for metabolic-related conditions Experimental concentrations typically depend on the specific research design allowing for tailored investigation based on intended outcomes and model systems used

Catalog No. 50-005-70090 Supplier Apexbio Technology LLC Supplier No. C6695200
May include imposed supplier surcharges.
Add to Cart
Add to Cart

missing translation for 'validMainframeMsg'

(R)-(-)-1 3-Butanediol (CAS No 6290-03-5) is a chiral compound utilized in various biomedical research fields due to its unique stereochemistry and metabolic properties Originating from natural fermentation processes and synthetic methods it acts primarily on metabolic pathways associated with energy production This compound is known for its ability to affect cellular energy balance influencing pathways involved in glycolysis and gluconeogenesis In vitro it displays activity typically in the nanomolar to low micromolar range making it suitable for precise biochemical studies Common applications include its use in cell models to study metabolic disorders in animal studies to evaluate neurological effects and in drug screening as a potential therapeutic agent for metabolic-related conditions Experimental concentrations typically depend on the specific research design allowing for tailored investigation based on intended outcomes and model systems used

Product Title
Select an issue

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.